Blandine Cherifi-Gatta
Professeur d'université - Praticien hospitalier
MD-PhD (PU PH) / Université de Bordeaux / CHU/ Contact
+33 5 57 65 62 35
/ Adresse
Neurocentre Magendie - INSERM U 1215 - 146, rue Léo Saignat - 33077 Bordeaux
Publications
-
Quantitative MRI biomarkers measure changes in targeted brain areas in patients with obesity.
The Journal of Clinical Endocrinology & Metabolism. 2024-01-09.
10.1210/clinem/dgae014 -
Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample
Drug and Alcohol Dependence. 2023-10-01. 251 : 110937.
10.1016/j.drugalcdep.2023.110937 -
Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
The Journal of Clinical Endocrinology & Metabolism. 2020-04-25. 105(7) : e2511-e2520.
10.1210/clinem/dgaa193 -
Étude des interactions entre le système endocannabinoïde et la pathologie de l’axe corticotrope chez l’Homme
Annales d'Endocrinologie. 2018-09-01. 79(4) : 286.
10.1016/j.ando.2018.06.271 -
P2101 Effet d’un régime hypoglucidique sur le métabolisme et les concentrations plasmatiques des endocannabinoïdes chez des patients diabétiques de type 2
Diabetes & Metabolism. 2013-03-01. 39 : A92.
10.1016/s1262-3636(13)72011-1 -
Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity
Curr Obes Rep. 2012-08-17. 1(4) : 229-235.
10.1007/s13679-012-0027-6 -
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
Int J Obes Relat Metab Disord. 2011-08-16. 36(6) : 880-885.
10.1038/ijo.2011.165